Subject(s)
Humans , Male , Adult , Substance Abuse, Oral , Tomography, Optical Coherence , Visual Acuity , Hypertensive RetinopathySubject(s)
Cocaine , Hypertension , Hypertensive Retinopathy , Humans , Hypertension/etiology , Cocaine/adverse effectsABSTRACT
Antecedentes: Ambu® AuraGain® es un dispositivo supraglótico de segunda generación de un solo uso, recientemente lanzado al mercado, que permite la intubación traqueal guiada con fibrobroncoscopio. El principal objetivo del presente estudio multicéntrico fue evaluar el éxito global de Ambu AuraGain como dispositivo de ventilación en una amplia gama de indicaciones y características de pacientes. Métodos: Se incluyeron un total de 250 pacientes adultos con estado físico ASA i a iii, procedentes de cinco hospitales de España, que recibieron anestesia general y en los que se utilizó para el manejo de la vía aérea AuraGain. Resultados: El objetivo primario se evaluó en 244 pacientes y AuraGain fue efectiva en el 97,2% de las intervenciones (IC 95%, 0,99-0,94) durante todo el procedimiento. La mediana de la presión de fuga orofaríngea (PFO) fue de 32 cm H2O (RIQ 28-36 cm H2O). La inserción se logró en el primer intento en el 85% de los casos, y de forma global en el 98% de los casos, con una media de tiempo de inserción de 15 s (12-22,5), aunque el 61% de los pacientes requirió maniobras para facilitar su inserción. La inserción de la sonda gástrica se realizó fácilmente en el 99,6% de los pacientes, y la visión fibroscópica mostró visión de las cuerdas vocales en el 96,3% de los casos. Mediante análisis de regresión logística se identificó que el uso de tamaños más pequeños que los recomendados fue un factor asociado a una baja PFO (< 25 cm H2O). La principal complicación registrada fue la presencia de sangre en la retirada del dispositivo (15%). Conclusiones: Nuestros resultados confirman que el uso de AuraGain® proporciona una ventilación fiable y eficaz, logrando un alto nivel de PFO constante en una amplia gama de indicaciones. El éxito de funcionamiento global fue consistente en los cinco centros, con una baja incidencia de complicaciones asociadas.(AU)
Purpose: The main objective of this study was to evaluate the performance of the Ambu AuraGain device by determining its main parameters of use and complications. Methods: A total of 250 adult ASA physical status i to iii patients from five hospitals in Spain who received general anaesthesia with a supraglottic airway (SGA) device were enrolled in this study. Results: The primary outcome was analysed for 244 patients and a median OLP of 32 cm H2O (IQR 28-36 cm H2O) was obtained. Insertion was achieved at first attempt in 85% of cases, and overall in 98% of cases, in a median time of 15 s (12-22.5). We applied manoeuvres in 61% of patients to facilitate the process. Ventilation was effective in 97.2% of the interventions (95% CI 0.99-0.94) throughout the procedure. Insertion of the gastric tube was easily performed in 99.6% of the patients, and the vocal cords were viewed by fibrobronchoscopy in 96.3% of cases. Logistic regression analysis identified the use of sizes smaller than those recommended as a risk factor for low OLP (< 25 cm H2O). The main complication recorded was the presence of blood when withdrawing the SGA device (15%). Conclusions: Our results confirm that the use of AuraGain allows airway management in a reliable and effective way achieving high OLP and low incidence of associated complications, establishing it as a useful alternative in the routine clinical setting of anaesthesiologists. AuraGain performance was consistent in all five centres.(AU)
Subject(s)
Humans , Male , Female , Adult , Anesthesiologists , Surgical Clearance , Anesthesia, General , Respiratory System , Airway Management/methods , Laryngeal Masks , Prospective Studies , Spain , Anesthesiology , RespirationABSTRACT
PURPOSE: The main objective of this study was to evaluate the performance of the Ambu™ AuraGain™ device by determining its main parameters of use and complications. METHODS: A total of 250 adult ASA physical status i to iii patients from five hospitals in Spain who received general anaesthesia with a supraglottic airway (SGA) device were enrolled in this study. RESULTS: The primary outcome was analysed for 244 patients and a median OLP of 32 cm H2O (IQR 28-36 cm H2O) was obtained. Insertion was achieved at first attempt in 85% of cases, and overall in 98% of cases, in a median time of 15 s (12-22.5). We applied manoeuvres in 61% of patients to facilitate the process. Ventilation was effective in 97.2% of the interventions (95% CI 0.99-0.94) throughout the procedure. Insertion of the gastric tube was easily performed in 99.6% of the patients, and the vocal cords were viewed by fibrobronchoscopy in 96.3% of cases. Logistic regression analysis identified the use of sizes smaller than those recommended as a risk factor for low OLP (< 25 cm H2O). The main complication recorded was the presence of blood when withdrawing the SGA device (15%). CONCLUSIONS: Our results confirm that the use of AuraGain allows airway management in a reliable and effective way achieving high OLP and low incidence of associated complications, establishing it as a useful alternative in the routine clinical setting of anaesthesiologists. AuraGain performance was consistent in all five centres.
Subject(s)
Laryngeal Masks , Adult , Airway Management , Anesthesia, General/adverse effects , Humans , Incidence , RespirationABSTRACT
BACKGROUND: Perioperative hypothermia is a common complication during general anesthesia. Although rewarming of patients before surgery has been used as a preventive measure and some guidelines recommend it, the implementation of prewarming for every surgical patient is cumbersome. Therefore, we sought to determine the efficacy of two novel prewarming methods that could facilitate prewarming in daily practice. METHODS: This was a prospective, randomized, multi-center, controlled study. After IRB approval and informed consent, 90 patients undergoing surgery of 30-120 min duration with general anesthesia were randomly assigned to three groups: 1) standard preoperative insulation (Group A); 2) passive preoperative insulation with a commercial prewarming suit (Group B); 3) active preoperative prewarming with a forced-air warmer connected to a prewarming suit (Group C). All patients received warmed IV fluids and intraoperative forced air warming after induction of anesthesia. Oral temperatures were recorded in the preoperative and postoperative periods. Intraoperative core temperatures were measured with an esophageal probe. RESULTS: Repeated-measures analysis of variance (ANOVA) and post hoc Scheffé's test identified a significantly higher core temperature in the actively prewarmed group (Group C) compared to both passive groups (A, B) at 15, 30, 45, 60, and 75 min (P<0.05) after induction of anesthesia and at the end of surgery. During the first 30 min after admission at PACU, also higher oral temperatures were measured in Group C, compared with both passive insulation groups. CONCLUSION: In our study active prewarming with a forced-air warmer and an insulating prewarming suit achieves significantly higher core temperatures during anesthesia and at the end of surgery and avoids hypothermia at the end of surgery compared to commercial or conventional insulation techniques.
Subject(s)
Anesthesia, General , Hypothermia/prevention & control , Intraoperative Complications/prevention & control , Postoperative Complications/prevention & control , Adult , Female , Heating , Humans , Male , Middle Aged , Preoperative Care , Prospective StudiesSubject(s)
Algorithms , Ambulatory Surgical Procedures , Intubation, Intratracheal/methods , Adult , Decision Trees , Glottis , HumansABSTRACT
Taking part of the Program for The Inventory of Flora and Fauna of Coiba Island National Park (Panama), a first list of oribatid mites (Acari: Oribatei) is presented. Materials studied come from several soil samplings, including humus and fallen leaves, done in Coiba Island in July 1998. 134 species were identified from a total amount of 1053 individuals collected. Almost all the identified species are new records for Panama as well as eigth species that represent first records for the Neotropical Region. A new name is given: Aeroppia mariehammerae n. nom. for Aeroppia sp. and a new combination is proposed: Protoribates antillensis (Mahunka, 1985) n. comb. (Xylobates).
